Tissue Modeling

BPC-157 / KPV / Larazotide (Gut Blend)

BPC-157 + KPV + Larazotide acetate capsule blend

$95.00

Format Capsules, bottle
Purity ≥99% (HPLC)
Component CAS BPC-157: 137525-51-0; KPV: 67727-97-3; Larazotide acetate: 881851-50-9
Documentation COA by request

This product is intended for in-vitro and pre-clinical research purposes only. It is not intended for human consumption, nor for use as a drug, food additive, or household chemical. These statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, the customer acknowledges all risks of handling and distribution, and agrees to indemnify Sokai Sciences against any claims arising from misuse.

FAQ

Common questions

What three peptides are in this gut blend?+

BPC-157, KPV, and Larazotide acetate.

What is Larazotide acetate?+

A zonulin-antagonist peptide referenced in the published celiac-disease clinical-trial literature.

Is each component tested for purity?+

Yes, verified per component on the COA.

About

About BPC-157 / KPV / Larazotide (Gut Blend)

A fixed-ratio capsule blend combining three independently studied peptides — BPC-157 (CAS 137525-51-0), KPV (CAS 67727-97-3), and Larazotide acetate (CAS 881851-50-9), a zonulin-antagonist peptide referenced in the celiac-disease clinical-trial literature — encapsulated for oral-route research designs. For laboratory research use only.